Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Elucidation of Additional Mutations By Next-Generation Sequencing Is of Clinical Significance in Patients with Rare MPNs and MDS/MPN Overlap Syndromes

Martin MJ Kirschner, MD, Mirle Schemionek, PhD, Matthias Begemann, PhD, Susanne Isfort, MD, Kristina Feldberg, Tim H. Brümmendorf, MD, Steffen Koschmieder, MD

Blood (2016) 128 (22): 4260.

https://doi.org/10.1182/blood.V128.22.4260.4260

Published: 2016

Journal Articles

Classic Cardiovascular Risk Factors and Certain Comorbidities May Contribute to the Risk of Thrombembolic and Bleeding Events in Patients with Classical Myeloproliferative Neoplasms

Susanne Isfort, MD, Andrea Kaifie, MD, Karla Schmitt, MD, Edgar Jost, MD, Tim H. Bruemmendorf, MD, Steffen Koschmieder, MD

Blood (2015) 126 (23): 5195.

https://doi.org/10.1182/blood.V126.23.5195.5195

Published: 2015

Journal Articles

Comorbidity Scales in Patients with Myeloproliferative Neoplasms: Which One Fits Best?

Susanne Isfort, MD, Andrea Kaifie, MD, Karla Bennemann, MD, Edgar Jost, MD, Jens Panse, MD, Tim H Bruemmendorf, MD, Steffen Koschmieder, MD

Blood (2014) 124 (21): 1828.

https://doi.org/10.1182/blood.V124.21.1828.1828

Published: 2014

Journal Articles

Diagnosis and Treatment of Myeloproliferative Neoplasms in Germany: First Results from the SAL-MPN Registry

Andrea Kaifie, MD, Susanne Isfort, MD, Dominik Wolf, MD, Mathias Hanel, MD, Christoph Maintz, MD, Norbert Gattermann, MD PhD, Uwe Platzbecker, MD, Eray Goekkurt, MD, Ina Boeters, MD, Richard Hansen, MD, Fabian Lang, MD, Joachim R. Goethert, Karla Bennemann, MD, Christoph Rollig, MD MSC, Hubert Serve, MD, Wolfgang E Berdel, MD, Gerhard Ehninger, MD, Tim H Bruemmendorf, MD, Steffen Koschmieder, MD

Blood (2014) 124 (21): 5561.

https://doi.org/10.1182/blood.V124.21.5561.5561

Published: 2014

Journal Articles

Response and Overall Survival Is Impaired in Obese Patients with Acute Myelogenous Leukemia

Martina Crysandt, MD, Edgar Jost, MD, Susanne Isfort, MD, Tim H Brümmendorf, Stefan Wilop, MD

Blood (2012) 120 (21): 1522.

https://doi.org/10.1182/blood.V120.21.1522.1522

Published: 2012

Journal Articles

The Use of Chemoimmunotherapy Improves the Outcome of Patients with Chronic Lymphocytic Leukaemia (CLL) – a Metaanalysis of Five Trials of the German CLL Study Group (GCLLSG)

Paula Cramer, MD, Susanne Isfort, MD, Jasmin Bahlo, Raymonde Busch, Petra Langerbeins, MD, Anna-Maria Fink, MD, Valentin Goede, MD, Thomas Elter, MD, Manuela A. Bergmann, MD, Martina Beate Stauch, MD, Stephan Stilgenbauer, MD, Clemens-Martin Wendtner, MD, Kirsten Fischer, MD, Michael Hallek, MD PhD, Barbara F. Eichhorst, MD

Blood (2012) 120 (21): 3936.

https://doi.org/10.1182/blood.V120.21.3936.3936

Published: 2012

Journal Articles

Validity of Inclusion/Exclusion Criteria in Clinical Trials for Myelofibrosis and the Need for Expanded Access Programs [More Expanded Access Programs Are Needed to Assess the Impact of Comorbidity and Comedication in Patients with Myelofibrosis]

Susanne Isfort, MD, Edgar Jost, MD, Karla Bennemann, MD, Martina Crysandt, MD, Sema Akin, Tim H Brümmendorf, Steffen Koschmieder, MD

Blood (2012) 120 (21): 5063.

https://doi.org/10.1182/blood.V120.21.5063.5063

Published: 2012

NARROW

Elucidation of Additional Mutations By Next-Generation Sequencing Is of Clinical Significance in Patients with Rare MPNs and MDS/MPN Overlap Syndromes

Classic Cardiovascular Risk Factors and Certain Comorbidities May Contribute to the Risk of Thrombembolic and Bleeding Events in Patients with Classical Myeloproliferative Neoplasms

Comorbidity Scales in Patients with Myeloproliferative Neoplasms: Which One Fits Best?

Diagnosis and Treatment of Myeloproliferative Neoplasms in Germany: First Results from the SAL-MPN Registry

Response and Overall Survival Is Impaired in Obese Patients with Acute Myelogenous Leukemia

The Use of Chemoimmunotherapy Improves the Outcome of Patients with Chronic Lymphocytic Leukaemia (CLL) – a Metaanalysis of Five Trials of the German CLL Study Group (GCLLSG)

Validity of Inclusion/Exclusion Criteria in Clinical Trials for Myelofibrosis and the Need for Expanded Access Programs [More Expanded Access Programs Are Needed to Assess the Impact of Comorbidity and Comedication in Patients with Myelofibrosis]

Email alerts

ASH Publications

American Society of Hematology

Elucidation of Additional Mutations By Next-Generation Sequencing Is of Clinical Significance in Patients with Rare MPNs and MDS/MPN Overlap Syndromes

Classic Cardiovascular Risk Factors and Certain Comorbidities May Contribute to the Risk of Thrombembolic and Bleeding Events in Patients with Classical Myeloproliferative Neoplasms

Comorbidity Scales in Patients with Myeloproliferative Neoplasms: Which One Fits Best?

Diagnosis and Treatment of Myeloproliferative Neoplasms in Germany: First Results from the SAL-MPN Registry

Response and Overall Survival Is Impaired in Obese Patients with Acute Myelogenous Leukemia

The Use of Chemoimmunotherapy Improves the Outcome of Patients with Chronic Lymphocytic Leukaemia (CLL) – a Metaanalysis of Five Trials of the German CLL Study Group (GCLLSG)

Validity of Inclusion/Exclusion Criteria in Clinical Trials for Myelofibrosis and the Need for Expanded Access Programs [More Expanded Access Programs Are Needed to Assess the Impact of Comorbidity and Comedication in Patients with Myelofibrosis]

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only